Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. (CON) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
con · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Concentra Group Holdings Parent, Inc. (CON) measures how much investors pay for each dollar of the company's trailing earnings. CON's current PE ratio of 18.12x is calculated by dividing its stock price of $25.46 by its TTM earnings per share of $1.41. +18.9% elevated vs 5Y avg 15.2x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 5 fiscal years · Front-end computedMinQ1 · 25%15.2x
MedianQ3 · 75%17.1x
Max
At 18.12x, CON's current P/E is higher than in 100% of its annual fiscal year readings over the past 5 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Equipment & Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Concentra Group Holdings Parent, Inc.You CON | $3.3B | 18.12x | +11.4% | $1.41 |
 Addus HomeCare Corporation ADUS | $1.7B | 20.66x | +27.0% | $5.20 |
 Beam Therapeutics Inc. BEAM | $3.1B | N/A | — | -$0.81 |
 Bausch Health Companies Inc. BHC | $1.9B | 16.14x | -0.8% | $0.43 |
 Catalyst Pharmaceuticals, Inc. CPRX | $3.8B | 13.32x | -18.1% | $1.75 |
 Haemonetics Corporation HAE | $3.4B | 26.20x | +61.1% | $2.06 |
 HUTCHMED (China) Limited HCM | $1.9B | 4.99x | -69.3% | $2.67 |
Industry Average 5 peers with valid PE | — | 16.26x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 14.42x | $1.36 | -5.2% | |
2024-12-31 FY2024 | 15.22x | $1.30 | -3.8% | |
2023-12-31 FY2023 | 15.81x | $1.42 | -7.3% | |
2022-12-31 FY2022 | 17.07x | $1.32 | +25.3% | |
2021-12-31 FY2021 | 13.62x | $1.65 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Concentra Group Holdings Parent, Inc. (CON) measures how much investors pay for each dollar of the company's trailing earnings. CON's current PE ratio of 18.12x is calculated by dividing its stock price of $25.46 by its TTM earnings per share of $1.41.
Frequently asked questions
CON pe ratio · 6 questionsCON's current PE ratio is 18.12x as of 2026-06-08, based on a stock price of $25.46 and TTM EPS of $1.41. Data sourced from Financial Modeling Prep via CON's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Concentra Group Holdings Parent, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08